Screening for nonviral sexually transmitted infections in adolescents and young adults

Pediatrics

Volumn 134, Issue 1, 2014, Pages

  Murray, Pamela J ^f   Braverman, Paula K ^f   Adelman, William P ^f   Breuner, Cora C ^f   Levine, David A ^f   Marcell, Arik V ^f   O'Brien, Rebecca F ^f   Gavin, Loretta E ^a   Miller, Rachel J ^b   Omar, Hatim A ^c   Pinzon, Jorge L ^d   Shain, Benjamin ^e   Smith, Karen ^f   Monte, Mark Del ^f   Burstein, Gale R ^f  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^c Section on Adolescent Health   (United States)

^d Canadian Pediatric Society   (Canada)

^e American Academy of Child and Adolescent Psychiatry   (United States)

^f NONE

Author keywords

Chlamydia; Gonorrhea; Nonviral STIs; Screening; Sexually transmitted infections; Syphilis

Indexed keywords

ADOLESCENT; CHLAMYDIACEAE INFECTION; CLINICAL FEATURE; GONORRHEA; HEALTH CARE POLICY; HUMAN; INFECTION RATE; LABORATORY TEST; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; ATTITUDE TO HEALTH; CLINICAL PRACTICE; FEMALE; MALE; MASS SCREENING; MEDICAL SOCIETY; PEDIATRICS; PRACTICE GUIDELINE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; STANDARDS; YOUNG ADULT;

ADOLESCENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; PEDIATRICS; PRACTICE PATTERNS, PHYSICIANS'; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SOCIETIES, MEDICAL; YOUNG ADULT;

EID: 84904189116     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1024     Document Type: Review

References (84)

1. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Healthy People 2020. Washington, DC. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx? topicId=37. Accessed January 22, 2014
2. US Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147(2):128-134
3. US Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med . 2005;3(3):263-267
4. US Preventive Services Task Force. Screening for syphilis infection in pregnancy 2009. 2011. Available at: http://www.uspreventiveservicestaskforce. org/uspstf/uspssyphpg.htm. Accessed January 22, 2014
5. US Preventive Services Task Force. Screening for syphilis infection, topic page. July 2004. Available at: http://www.uspreventiveservicestaskforce. org/3rduspstf/syphilis/syphilrs.htm. Accessed January 22, 2014
6. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Recomm Rep. 2011;60(1):18 (Note: Dosage error in article text)]. MMWR Recomm Rep. 2010;59(RR-12):1-110
7. Centers for Disease Control and Prevention. Recommendations for Public Health Surveillance of Syphilis in the United States . Atlanta, GA: Centers for Disease Control and Prevention; 2003
8. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2012. Available at: http://www.cdc.gov/std/stats12/default.htm. Accessed January 22, 2014
9. American College of Obstetricians and Gynecologists. Guidelines for Women's Health Care: A Resource Manual. 3rd ed. Washington, DC: American College of Obstetricians and Gynecologists; 2007
10. American Academy of Family Physicians. Recommendations for Clinical Preventive Services. Leawood, KS: American Academy of Family Physicians; 2010
11. American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup. 2014 recommendations for pediatric preventive health care. Pediatrics. 2014;133(3):568-570
12. Braverman PK, Breech L; Committee on Adolescence. American Academy of Pediatrics. Clinical report - gynecologic examination for adolescents in the pediatric office setting. Pediatrics. 2010;126(3):583-590
13. Marcell AV, Wibbelsman C, Seigel WM. Male adolescent sexual and reproductive health care. Pediatrics. 2011;128(6). Available at: www.pediatrics.org/cgi/content/full/128/6/e1658
14. Blythe MJ, Del Beccaro MA; Committee on Adolescence; Council on Clinical and Information Technology. Standards for health information technology to ensure adolescent privacy. Pediatrics. 2012;130(5):987-990
15. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147(2):89-96 (Pubitemid 351664612)
16. Holmes K, Sparling P, Stamm W, et al. Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill Professional; 2008
17. Gottlieb SL, Brunham RC, Byrne GI, Martin DH, Xu F, Berman SM. Introduction: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for chlamydia control. J Infect Dis . 2010;201(suppl 2):S85-S87
18. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010;201(suppl 2):S134-S155
19. Røttingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28(10):579-597 (Pubitemid 32937567)
20. Baeten JM, Overbaugh J. Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res. 2003;1(1):69-86
21. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3 -17
22. Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183-190
23. Rieg G, Butler DM, Smith DM, Daar ES. Seminal plasma HIV levels in men with asymptomatic sexually transmitted infections. Int J STD AIDS. 2010;21(3):207-208
24. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med. 2001;20(3 Suppl):95-107 (Pubitemid 33732973)
25. Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012
26. Tracy CR, Steers WD, Costabile R. Diagnosis and management of epididymitis. Urol Clin North Am. 2008;35(1):101-108, vii (Pubitemid 350166525)
27. Kousa M, Saikku P, Richmond S, Lassus A. Frequent association of chlamydial infection with Reiter 's syndrome. Sex Transm Dis. 1978;5(2):57-61
28. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med. 2006;31(1):52-61 (Pubitemid 43956597)
29. Kirzinger WK, Cohen RA, Gindi RM. Health care access and utilization among young adults aged 19-25: early release of estimates from the National Health Interview Survey, January-September, 2011. Atlanta, GA: National Center for Health Statistics; May 2012. Available at: www.cdc.gov/nchs/data/nhis/ earlyrelease/Young-Adults-Health-Access-052012.pdf. Accessed January 22, 2014
30. Centers for Disease Control and Prevention. Male Chlamydia Screening Consultation Meeting Report. Atlanta, GA: Centers for Disease Control and Prevention; May 22, 2007
31. Gift TL, Blake DR, Gaydos CA, Marrazzo JM. The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature. Sex Transm Dis. 2008;35(suppl 11):S51-S60
32. Gift TL, Gaydos CA, Kent CK, et al. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis. 2008;35(suppl 11):S66-S75
33. Schillinger JA, Dunne EF, Chapin JB, et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities. Sex Transm Dis. 2005;32(2):74-77
34. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63(RR-2):1-19
35. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med . 2005;142(11):914-925 (Pubitemid 40791807)
36. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol . 2010;48(5):1827-1832
37. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642
38. Scholes D, Satterwhite CL, Yu O, Fine D, Weinstock H, Berman S. Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population. Sex Transm Dis. 2012;39(2):81-88
39. Tebb KP, Wibbelsman C, Neuhaus JM, Shafer MA. Screening for asymptomatic Chlamydia infections among sexually active adolescent girls during pediatric urgent care. Arch Pediatr Adolesc Med. 2009;163(6):559-564
40. Burstein GR, Snyder MH, Conley D, et al. Chlamydia screening in a health plan before and after a national performance measure introduction. Obstet Gynecol. 2005;106(2):327-334 (Pubitemid 41023271)
41. Shafer MA, Tebb KP, Pantell RH, et al. Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA. 2002;288(22):2846-2852 (Pubitemid 35425070)
42. Maloney SK, Johnson C. Why Screen for Chlamydia? An Implementation Guide for Healthcare Providers. Washington, DC: Partnership for Prevention; 2008
43. Gaydos CA, Barnes M, Aumakhan B, et al. Can e-technology through the Internet be used as a new tool to address the Chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sex Transm Dis. 2009;36(9):577-580
44. Cook RL, Østergaard L, Hillier SL, et al; DAISY study team. Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect. 2007;83(4):286-291 (Pubitemid 47242507)
45. Pugsley RA, Chapman DA, Kennedy MG, Liu H, Lapane KL. Residential segregation and gonorrhea rates in US metropolitan statistical areas, 2005-2009. Sex Transm Dis. 2013;40(6):439-443
46. Harry TC, Black PD. Unilateral gonococcal ophthalmia without genital infection: an unusual presentation in an adult. Int J STD AIDS. 2005;16(1):78-79 (Pubitemid 40193669)
47. Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol. 2008;77(1):32-40
48. Centers for Disease Control and Prevention (CDC). Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations-five cities, United States, 2007. MMWR Morb Mortal Wkly Rep. 2009;58(26):716-719
49. Satterwhite C, Gottlieb S, Romaguera R, et al Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep. 2011;60(12):370-373
50. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67-74 (Pubitemid 40863746)
51. Bachmann LH, Johnson RE, Cheng H, Markowitz LE, Papp JR, Hook EW III. Nucleic acid ampli fication tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol . 2009;47(4):902-907
52. Centers for Disease Control and Prevention (CDC). Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000 -2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):873-877
53. Centers for Disease Control and Prevention (CDC). Neisseria gonorrhoeae with reduced susceptibility to azithromycin-San Diego County, California, 2009. MMWR Morb Mortal Wkly Rep. 2011;60(18):579-581
54. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007;45(10):1319-1326 (Pubitemid 351411908)
55. Miller WC, Zenilman JM. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States-2005. Infect Dis Clin North Am . 2005;19(2):281-296 (Pubitemid 40814415)
56. Forhan SE, Gottlieb SL, Sternberg MR, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124(6):1505-1512
57. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, et al. Trichomonas vaginalis prevalence, incidence, risk factors and antibioticresistance in an adolescent population. Sex Transm Dis. 2010;37(7):440-444
58. Cherpes TL, Wiesenfeld HC, Melan MA, et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33(12):747-752 (Pubitemid 44832936)
59. Paisarntantiwong R, Brockmann S, Clarke L, Landesman S, Feldman J, Minkoff H. The relationship of vaginal trichomoniasis and pelvic inflammatory disease among women colonized with Chlamydia trachomatis. Sex Transm Dis. 1995;22(6):344-347
60. Swadpanich U, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev. 2008;(2):CD006178
61. Cotch MF, Pastorek JG, II, Nugent RP, et al The Vaginal Infections and Prematurity Study Group. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis. 1997;24(6):353-360 (Pubitemid 27306585)
62. Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 1984;150(8):965-972 (Pubitemid 15232024)
63. Kissinger PJ, Reilly K, Taylor SN, Leichliter JS, Rosenthal S, Martin DH. Early repeat Chlamydia trachomatis and Neisseria gonorrhoeae infections among heterosexual men. Sex Transm Dis. 2009;36(8):498-500
64. Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol. 2006;44(2):366-373 (Pubitemid 43222224)
65. Krieger JN, Coombs RW, Collier AC, et al. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol. 1995;154(3):1035-1040
66. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999;26(7):381-387 (Pubitemid 29372769)
67. Seña AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44(1):13-22 (Pubitemid 44968978)
68. Roth AM, Williams JA, Ly R, et al. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among highrisk female populations. Sex Transm Dis. 2011;38(5):398-400
69. Smith KS, Tabrizi SN, Fethers KA, Knox JB, Pearce C, Garland SM. Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas. Int J STD AIDS. 2005;16(12):811-815 (Pubitemid 43116702)
70. Radonjic IV, Dzamic AM, Mitrovic SM, Arsic Arsenijevic VS, Popadic DM, Kranjcic Zec IF. Diagnosis of Trichomonas vaginalis infection: the sensitivities and specificities of microscopy, culture and PCR assay. Eur J Obstet Gynecol Reprod Biol. 2006;126(1):116-120
71. Patel SR, Wiese W, Patel SC, Ohl C, Byrd JC, Estrada CA. Systematic review of diagnostic tests for vaginal trichomoniasis. Infect Dis Obstet Gynecol. 2000;8(5-6):248-257 (Pubitemid 32114475)
72. Hardick A, Hardick J, Wood BJ, Gaydos C. Comparison between the Gen-Probe transcriptionmediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female selfobtained vaginal swab samples and male urine samples. J Clin Microbiol. 2006;44(11):4197-4199 (Pubitemid 44737270)
73. Peterman TA, Tian LH, Metcalf CA, et al; RESPECT-2 Study Group. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med. 2006;145(8):564-572 (Pubitemid 46780935)
74. Association of Public Health Laboratories, Centers for Disease Control and Prevention. Laboratory diagnostic testing for Treponema pallidum: expert consultation meeting summary report. Silver Spring, MD: Association of Public Health Laboratories; 2009. Available at: http://www.aphl.org/aphlprograms/ infectious/std/Documents/ID-2009Jan-Laboratory-Guidelines-Treponema-pallidum- Meeting-Report.pdf. Accessed January 22, 2014
75. Barros FC, Bhutta ZA, Batra M, Hansen TN, Victora CG, Rubens CE; GAPPS Review Group. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions. BMC Pregnancy Childbirth. 2010;10(suppl 1):S3
76. Herbst JH, Jacobs ED, Finlayson TJ, McKleroy VS, Neumann MS, Crepaz N; HIV/AIDS Prevention Research Synthesis Team. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1-17 (Pubitemid 351143456)
77. Schulden JD, Song B, Barros A, et al. Rapid HIV testing in transgender communities by community-based organizations in three cities. Public Health Rep. 2008;123(suppl 3):101-114
78. Duncan B, Hart G, Scoular A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ. 2001;322(7280):195-199 (Pubitemid 32116161)
79. Duncan PM, Duncan ED, Swanson J. Bright Futures: the screening table recommendations. Pediatr Ann. 2008;37(3):152-158 (Pubitemid 351542956)
80. Pimenta JM, Catchpole M, Rogers PA, et al. Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases. Sex Transm Infect. 2003;79(1):22-27 (Pubitemid 36237822)
81. Darroch J, Myers L, Cassell J. Sex differences in the experience of testing positive for genital chlamydia infection: a qualitative study with implications for public health and for a national screening programme. Sex Transm Infect. 2003;79(5):372-373
82. Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening-four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep. 2008;57(32):872-875
83. Centers for Disease Control and Prevention. Legal Status of Expedited Partner Therapy (EPT). Atlanta, GA: Centers for Disease Control and Prevention; 2012. Available at: www.cdc.gov/std/ept/legal/default.htm. Accessed January 22, 2014
84. American Academy of Pediatrics, Committee on Adolescence. Condom use by adolescents. Pediatrics . 2013;132(5):973-981